SummaryRMgm-4901
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene mutation, Gene tagging |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 33600048 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | Not applicable |
Other information parent line | |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | Singer M, Frischknecht F |
Name Group/Department | Integrative Parasitology, Center for Infectious Diseases |
Name Institute | Heidelberg University Medical School |
City | Heidelberg |
Country | Germany |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-4901 |
Principal name | see below |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Not different from wild type |
Gametocyte/Gamete | Not different from wild type |
Fertilization and ookinete | Not different from wild type |
Oocyst | Normal numbers of oocysts are produced in all 5 lines. |
Sporozoite | 'Normal' sporozoite formation inside oocysts. Investigating the GFP-CSP localization revealed that all but the two SP-GFP-CSP lines showed the expected surface localization of the fusion proteins. Close inspection also revealed that the GPI-GFP expressing parasite often showed additional small vesicular localization in the proximity of the plasma membrane at the estimated nuclear exit site or Golgi localization. R-GFP-CSP and TSR-GFP-CSP but not SP-GFP-CSP localize to the plasma membrane. Strongly reduced numbers of salivary gland sporozoites. Evidence is presented that the expression of tagged proteins inhibited sporozoite egress from oocysts. |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation Strongly reduced numbers of salivary gland sporozoites. Evidence is presented that the expression of tagged proteins inhibited sporozoite egress from oocysts. Additional information |
top of page | |||||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_0403200 | ||||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_0304600 | ||||||||||||||||||||||||||
Gene product | circumsporozoite (CS) protein | ||||||||||||||||||||||||||
Gene product: Alternative name | CSP | ||||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||||
Short description of the mutation | A series of mutants expressing an additional copy of CSP, tagged with GFP at different locations | ||||||||||||||||||||||||||
Inducable system used | No | ||||||||||||||||||||||||||
Short description of the conditional mutagenesis | Not available | ||||||||||||||||||||||||||
Additional remarks inducable system | |||||||||||||||||||||||||||
Type of plasmid/construct | (Linear) plasmid single cross-over | ||||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | hdhfr | ||||||||||||||||||||||||||
Promoter of the selectable marker | eef1a | ||||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||||
Additional remarks genetic modification | The following five parasite lines were generated: - GFP-GPI, parasites expressing a protein consisting of the signal peptide of CSP, GFP and the C-terminal 22 amino acids of CSP corresponding to the GPI-anchor sequence. This line was obtained through insertion at a silent locus in chromosome 12 of P. berghei strain ANKA. - SP-GFP-CSP_add, parasites expressing a CSP-GFP fusion protein with the GFP placed between the signal peptide (SP) and the N-terminus of CSP. This line, expressed SP-GFP-CSP in addition to the endogenous CSP and was obtained by linear insertion of the sp-gfp-csp plasmid into the csp locus on chromosome 4. - SP-GFP-CSP_rep, where the endogenous csp was replaced by the sp-gfp-csp gene. - R-GFP-CSP, where the GFP was placed between the repeat region and TSR of CSP - TSR-GFP-CSP; where the GFP was placed between the TSR and the GPI-anchor. Exact positioning of the GFP insertion sites for R-GFP-CSP and TSR-GFP-CSP was assisted by the crystal structure of the TSR domain. In these lines, the fusion proteins were also expressed in addition to the endogenous CSP as obtained by linear insertion of the respective plasmids into the csp locus on chromosome 4. Note that for SP-GFP-CSP_add, the DNA is inserted such that the resulting modified locus features an endogenous csp with a truncated 3’UTR and the fluorescent copy a truncated 5’UTR, while this is inversed for R-GFP-CSP and TSR-GFP-CSP. For SP-GFP-CSP_rep, the gene is flanked by the complete 5’UTR and 3’UTR. | ||||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
top of page |
top of page | |||||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_0403200 | ||||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_0304600 | ||||||||||||||||||||||||||
Gene product | circumsporozoite (CS) protein | ||||||||||||||||||||||||||
Gene product: Alternative name | CSP | ||||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||||
Name of the tag | GFP | ||||||||||||||||||||||||||
Details of tagging | different locations in the protein | ||||||||||||||||||||||||||
Additional remarks: tagging | A series of mutants expressing an additional copy of CSP, tagged with GFP at different locations | ||||||||||||||||||||||||||
Commercial source of tag-antibodies | |||||||||||||||||||||||||||
Type of plasmid/construct | (Linear) plasmid single cross-over | ||||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | hdhfr | ||||||||||||||||||||||||||
Promoter of the selectable marker | eef1a | ||||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||||
Additional remarks genetic modification | The following five parasite lines were generated: - GFP-GPI, parasites expressing a protein consisting of the signal peptide of CSP, GFP and the C-terminal 22 amino acids of CSP corresponding to the GPI-anchor sequence. This line was obtained through insertion at a silent locus in chromosome 12 of P. berghei strain ANKA. - SP-GFP-CSP_add, parasites expressing a CSP-GFP fusion protein with the GFP placed between the signal peptide (SP) and the N-terminus of CSP. This line, expressed SP-GFP-CSP in addition to the endogenous CSP and was obtained by linear insertion of the sp-gfp-csp plasmid into the csp locus on chromosome 4. - SP-GFP-CSP_rep, where the endogenous csp was replaced by the sp-gfp-csp gene. - R-GFP-CSP, where the GFP was placed between the repeat region and TSR of CSP - TSR-GFP-CSP; where the GFP was placed between the TSR and the GPI-anchor. Exact positioning of the GFP insertion sites for R-GFP-CSP and TSR-GFP-CSP was assisted by the crystal structure of the TSR domain. In these lines, the fusion proteins were also expressed in addition to the endogenous CSP as obtained by linear insertion of the respective plasmids into the csp locus on chromosome 4. Note that for SP-GFP-CSP_add, the DNA is inserted such that the resulting modified locus features an endogenous csp with a truncated 3’UTR and the fluorescent copy a truncated 5’UTR, while this is inversed for R-GFP-CSP and TSR-GFP-CSP. For SP-GFP-CSP_rep, the gene is flanked by the complete 5’UTR and 3’UTR. | ||||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
top of page |